Mikhail Yu. Syromyatnikov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mikhail Yu. Syromyatnikov has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
- Vasily N. Popov
Voronezh State University of Engineering Technologies
36 shared publications - Inna Burakova
Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia
27 shared publications - Yuliya Smirnova
Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria
27 shared publications - Mariya V. Gryaznova
Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia
24 shared publications - Polina D. Morozova
Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia
22 shared publications - Evgeniy V. Mikhaylov
All-Russian Research Veterinary Institute of Pathology, Pharmacology and Therapy
20 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 3,p. 58-64
Probiotic potential of Lactobacillus brevis and Lactococcus lactis isolates from cottage cheese whey
Currently, the search for new promising strains of lactic acid bacteria (LAB) for use as probiotic supplements in animal husbandry farming is a pressing issue. Cottage cheese whey, a by-product of dairy production characterized by low pH values and a specific chemical composition, serves as a natural habitat for phenotypically resistant strains potentially capable of surviving in the gastrointestinal tract of animals. In this study, two LAB strains, Lactobacillus brevis and Lactococcus lactis , were isolated and identified from a cottage cheese whey sample. A comprehensive assessment of their probiotic potential included the determination of antagonistic activity against Escherichia coli test strains, resistance to various pH values (2.0–8.0) and bile concentrations (10–40%), antibiotic susceptibility, as well as adhesive properties (autoaggregation, cell surface hydrophobicity, and biofilm formation ability). The results showed that both strains exhibit high antagonistic activity against E. coli . Meanwhile, L. lactis demonstrated very high efficacy (growth inhibition zones exceeding 20 mm) against two of the three test cultures. The most significant differences between the strains were revealed in the assessment of their resistance to gastrointestinal factors: L. brevis exhibited high resistance to low pH 2.0 (maintaining viability at >10⁸ CFU/mL) and high bile concentrations (up to 30%), whereas L. lactis was more sensitive to these stress factors. Both strains displayed multiple natural antibiotic resistance, which is typical for "wild" LAB strains; however, the antibiotic resistance profile of L. lactis was broader. In the assessment of adhesive properties, both strains were found to possess high cell surface hydrophobicity (>97%), with L. lactis significantly surpassing L. brevis in autoaggregation ability (86% vs. 41%) and moderate biofilm formation. The results of this comprehensive evaluation of the probiotic properties of strains isolated from cottage cheese whey open up prospects for the development of effective multi-strain probiotic preparations for farm animals.
- 25 October 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 3,p. 58-64
Open AccessProbiotic potential of Lactobacillus brevis and Lactococcus lactis isolates from cottage cheese whey
Currently, the search for new promising strains of lactic acid bacteria (LAB) for use as probiotic supplements in animal husbandry farming is a pressing issue. Cottage cheese whey, a by-product of dairy production characterized by low pH values and a specific chemical composition, serves as a natural habitat for phenotypically resistant strains potentially capable of surviving in the gastrointestinal tract of animals. In this study, two LAB strains, Lactobacillus brevis and Lactococcus lactis , were isolated and identified from a cottage cheese whey sample. A comprehensive assessment of their probiotic potential included the determination of antagonistic activity against Escherichia coli test strains, resistance to various pH values (2.0–8.0) and bile concentrations (10–40%), antibiotic susceptibility, as well as adhesive properties (autoaggregation, cell surface hydrophobicity, and biofilm formation ability). The results showed that both strains exhibit high antagonistic activity against E. coli . Meanwhile, L. lactis demonstrated very high efficacy (growth inhibition zones exceeding 20 mm) against two of the three test cultures. The most significant differences between the strains were revealed in the assessment of their resistance to gastrointestinal factors: L. brevis exhibited high resistance to low pH 2.0 (maintaining viability at >10⁸ CFU/mL) and high bile concentrations (up to 30%), whereas L. lactis was more sensitive to these stress factors. Both strains displayed multiple natural antibiotic resistance, which is typical for "wild" LAB strains; however, the antibiotic resistance profile of L. lactis was broader. In the assessment of adhesive properties, both strains were found to possess high cell surface hydrophobicity (>97%), with L. lactis significantly surpassing L. brevis in autoaggregation ability (86% vs. 41%) and moderate biofilm formation. The results of this comprehensive evaluation of the probiotic properties of strains isolated from cottage cheese whey open up prospects for the development of effective multi-strain probiotic preparations for farm animals.
- Open Access
- 11 August 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (8) , 153
Gut Microbiota in Type 2 Diabetes and Metabolic Disorders: Sources of Heterogeneity and Ways to Resolve Contradictions in Research
Metabolic diseases, including obesity and type 2 diabetes mellitus, represent a major global health burden and are closely linked to the composition and function of the gut microbiota. Advances in molecular methods have enabled detailed characterization of microbial communities and their interactions with diet, medications, and host physiology, positioning the microbiome as an active metabolic organ. However, the field faces persistent challenges in distinguishing causal relationships from associations, largely owing to substantial biological, exposure-related, and methodological heterogeneity. This review systematizes the principal lines of evidence connecting the gut microbiome to metabolic disorders and critically examines the sources of variability that limit reproducibility and cross-cohort transferability of these findings. We discuss the taxonomic, functional, and metabolite-based levels of microbiome analysis, evaluate the strengths and limitations of cross-sectional, case–control, cohort, and interventional study designs, and consider approaches for establishing causality, including fecal microbiota transplantation, Mendelian randomization, mediation analysis, causal diagrams, and triangulation of evidence. We conclude that only a comprehensive, standardized, and causally informed approach will allow reliable discrimination between true microbiota-driven effects and methodological artifacts, thereby advancing the integration of microbiome science into the management of metabolic diseases and diabetes.
- 11 August 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (8) , 153
Open AccessGut Microbiota in Type 2 Diabetes and Metabolic Disorders: Sources of Heterogeneity and Ways to Resolve Contradictions in Research
Metabolic diseases, including obesity and type 2 diabetes mellitus, represent a major global health burden and are closely linked to the composition and function of the gut microbiota. Advances in molecular methods have enabled detailed characterization of microbial communities and their interactions with diet, medications, and host physiology, positioning the microbiome as an active metabolic organ. However, the field faces persistent challenges in distinguishing causal relationships from associations, largely owing to substantial biological, exposure-related, and methodological heterogeneity. This review systematizes the principal lines of evidence connecting the gut microbiome to metabolic disorders and critically examines the sources of variability that limit reproducibility and cross-cohort transferability of these findings. We discuss the taxonomic, functional, and metabolite-based levels of microbiome analysis, evaluate the strengths and limitations of cross-sectional, case–control, cohort, and interventional study designs, and consider approaches for establishing causality, including fecal microbiota transplantation, Mendelian randomization, mediation analysis, causal diagrams, and triangulation of evidence. We conclude that only a comprehensive, standardized, and causally informed approach will allow reliable discrimination between true microbiota-driven effects and methodological artifacts, thereby advancing the integration of microbiome science into the management of metabolic diseases and diabetes.
- Open Access
- 30 June 2026
- Published by FSBEI HE Voronezh State University of Engineering Technologies in Proceedings of the Voronezh State University of Engineering Technologies
- Vol. 88 (2) , 238-244
Evaluation of the effect of the probiotic bacterium Streptococcus salivarius on the human intestine
Disturbances in the composition of the gut microbiota, known as dysbiosis, may contribute to the development of obesity, as they negatively affect the efficiency of energy harvest and metabolic processes in the body. One promising therapeutic approach to improving intestinal homeostasis is the use of probiotic supplements. The present study aimed to comprehensively evaluate the effect of the probiotic strain Streptococcus salivarius on the gut microbiota of volunteers with obesity. Microbiome profiles of volunteers before and after administration of a probiotic supplement containing the bacterial species S. salivarius were obtained using high-throughput sequencing on the DNBSEQ-G50 platform. Alpha diversity analysis was performed using observed species richness and the Shannon diversity index. No statistically significant differences were detected. Beta diversity analysis showed clustering between the study groups; however, no statistically significant differences were found. Differential abundance analysis revealed statistically significant species-level differences between the microbiomes of participants before and after intake of the dietary supplement. After supplementation, volunteers showed a decrease in the abundance of the following species: Phocaeicola vulgatus (8.469% ± 2.884 vs. 3.460% ± 0.864, p = 0.013) and Yeguia hominis (0.017% ± 0.005 vs. 0.007% ± 0.004, p = 0.017). In contrast, the relative abundance of the taxon GGB2970 SGB3952 (Firmicutes) increased during probiotic supplementation compared with baseline values obtained before supplementation (0.043% ± 0.012 vs. 0.087% ± 0.009, p = 0.001). The decrease in the relative abundance of Phocaeicola vulgatus and Yeguia hominis, together with the increase in GGB2970 SGB3952, indicates a directed shift in the taxonomic profile of the gut microbiota. The direction of these changes may be characterized as potentially beneficial. However, the physiological significance of these shifts requires further investigation, including analysis of the functional potential of the microbiota and associations with clinical parameters.
- 30 June 2026
- Published by FSBEI HE Voronezh State University of Engineering Technologies in Proceedings of the Voronezh State University of Engineering Technologies
- Vol. 88 (2) , 238-244
Open AccessEvaluation of the effect of the probiotic bacterium Streptococcus salivarius on the human intestine
Disturbances in the composition of the gut microbiota, known as dysbiosis, may contribute to the development of obesity, as they negatively affect the efficiency of energy harvest and metabolic processes in the body. One promising therapeutic approach to improving intestinal homeostasis is the use of probiotic supplements. The present study aimed to comprehensively evaluate the effect of the probiotic strain Streptococcus salivarius on the gut microbiota of volunteers with obesity. Microbiome profiles of volunteers before and after administration of a probiotic supplement containing the bacterial species S. salivarius were obtained using high-throughput sequencing on the DNBSEQ-G50 platform. Alpha diversity analysis was performed using observed species richness and the Shannon diversity index. No statistically significant differences were detected. Beta diversity analysis showed clustering between the study groups; however, no statistically significant differences were found. Differential abundance analysis revealed statistically significant species-level differences between the microbiomes of participants before and after intake of the dietary supplement. After supplementation, volunteers showed a decrease in the abundance of the following species: Phocaeicola vulgatus (8.469% ± 2.884 vs. 3.460% ± 0.864, p = 0.013) and Yeguia hominis (0.017% ± 0.005 vs. 0.007% ± 0.004, p = 0.017). In contrast, the relative abundance of the taxon GGB2970 SGB3952 (Firmicutes) increased during probiotic supplementation compared with baseline values obtained before supplementation (0.043% ± 0.012 vs. 0.087% ± 0.009, p = 0.001). The decrease in the relative abundance of Phocaeicola vulgatus and Yeguia hominis, together with the increase in GGB2970 SGB3952, indicates a directed shift in the taxonomic profile of the gut microbiota. The direction of these changes may be characterized as potentially beneficial. However, the physiological significance of these shifts requires further investigation, including analysis of the functional potential of the microbiota and associations with clinical parameters.
- Open Access
- 21 March 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (3) , 340
Probiotic Bacillus subtilis, but Not a Lactobacillus spp., Ameliorates Cognitive Impairment in a Mouse Model of LPS and Zidovudine-Induced Neuroinflammation
Background/Objectives: The gut–brain axis is increasingly recognized as a critical modulator of cognitive function. This study investigated the neurotoxic effects of combined exposure to bacterial lipopolysaccharide (LPS) and the antiretroviral drug zidovudine (ZDV) in a mouse model, and evaluated the protective potential of two probiotic interventions: Bacillus subtilis and a mixture of lactobacilli. Methods: Cognitive function was assessed using the Morris water maze (MWM). Gut microbiota composition was analyzed by 16S rRNA sequencing, and intestinal morphology was examined histologically. Gene expression of neuroinflammatory markers and mitophagy-related genes in brain tissue was quantified by RT-PCR. Plasma levels of cell-free mitochondrial DNA (cf-mtDNA) were measured as a marker of mitochondrial damage. Results: Combined LPS + ZDV exposure induced systemic inflammation, impaired spatial memory, damaged the intestinal mucosa, and caused dysbiosis characterized by an increase in pro-inflammatory Muribaculaceae. In the brain, LPS + ZDV significantly upregulated Tnfa expression, confirming neuroinflammation. Bacillus subtilis administration prevented cognitive deficits, maintained Tnfa at control levels, and significantly reduced Il1b and Il6 expression compared to the LPS + ZDV group. This was accompanied by activation of the PINK1/PTEN-dependent mitophagy pathway, prevention of cf-mtDNA release, and restoration of gut microbial diversity. In contrast, the Lactobacilli mixture not only failed to improve outcomes but was associated with exacerbated intestinal damage, more pronounced cognitive dysfunction, and no reduction in neuroinflammatory markers. Conclusions: Combined exposure to LPS and ZDV induces gut–brain axis dysfunction characterized by neuroinflammation, cognitive impairment, intestinal damage, and dysbiosis. Bacillus subtilis effectively preserves cognitive function through activation of PINK1/PTEN-dependent mitophagy and suppression of neuroinflammation, highlighting its potential as a therapeutic candidate for cognitive impairments associated with gut–brain axis dysfunction. The contrasting effects of the lactobacilli mixture underscore the critical importance of strain-specificity in probiotic interventions.
- 21 March 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (3) , 340
Open AccessProbiotic Bacillus subtilis, but Not a Lactobacillus spp., Ameliorates Cognitive Impairment in a Mouse Model of LPS and Zidovudine-Induced Neuroinflammation
Background/Objectives: The gut–brain axis is increasingly recognized as a critical modulator of cognitive function. This study investigated the neurotoxic effects of combined exposure to bacterial lipopolysaccharide (LPS) and the antiretroviral drug zidovudine (ZDV) in a mouse model, and evaluated the protective potential of two probiotic interventions: Bacillus subtilis and a mixture of lactobacilli. Methods: Cognitive function was assessed using the Morris water maze (MWM). Gut microbiota composition was analyzed by 16S rRNA sequencing, and intestinal morphology was examined histologically. Gene expression of neuroinflammatory markers and mitophagy-related genes in brain tissue was quantified by RT-PCR. Plasma levels of cell-free mitochondrial DNA (cf-mtDNA) were measured as a marker of mitochondrial damage. Results: Combined LPS + ZDV exposure induced systemic inflammation, impaired spatial memory, damaged the intestinal mucosa, and caused dysbiosis characterized by an increase in pro-inflammatory Muribaculaceae. In the brain, LPS + ZDV significantly upregulated Tnfa expression, confirming neuroinflammation. Bacillus subtilis administration prevented cognitive deficits, maintained Tnfa at control levels, and significantly reduced Il1b and Il6 expression compared to the LPS + ZDV group. This was accompanied by activation of the PINK1/PTEN-dependent mitophagy pathway, prevention of cf-mtDNA release, and restoration of gut microbial diversity. In contrast, the Lactobacilli mixture not only failed to improve outcomes but was associated with exacerbated intestinal damage, more pronounced cognitive dysfunction, and no reduction in neuroinflammatory markers. Conclusions: Combined exposure to LPS and ZDV induces gut–brain axis dysfunction characterized by neuroinflammation, cognitive impairment, intestinal damage, and dysbiosis. Bacillus subtilis effectively preserves cognitive function through activation of PINK1/PTEN-dependent mitophagy and suppression of neuroinflammation, highlighting its potential as a therapeutic candidate for cognitive impairments associated with gut–brain axis dysfunction. The contrasting effects of the lactobacilli mixture underscore the critical importance of strain-specificity in probiotic interventions.
- Open Access
- 6 March 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (3) , 592
Effect of a Combination of Prebiotic Supplements Based on Fucus and Kelp on the Gut Microbiome of Mice with Induced Inflammation
Gut microbiota imbalances can lead to the development of various inflammatory diseases in the body. The development of drugs aimed at maintaining intestinal health is a key area of biotechnology. Algae-based prebiotics are one such drug. The aim of this study was to conduct a comparative analysis of the fecal microbiota of Mus musculus with and without a prebiotic supplement. We studied the effects of enzymatically processed Laminaria digitata and Fucus vesiculosus seaweeds on the gut microbiome of mice with induced inflammation using DNBSEQ-G50 sequencing. The results showed that these prebiotic supplements can reduce the impact of inflammation on the intestine. An increase in the relative abundance of Anaerostipes rhamnosivorans, Dysosmobacter welbionis, Akkermansia muciniphila, Flavonifractor plautii, and a decrease in Longicatena caecimuris relative to the LPS group were observed. Furthermore, enzymatically processed algae were found to increase the relative abundance of gut bacterial metabolic pathways responsible for glucose breakdown. Thus, both enzymatically processed and unprocessed algae-based prebiotic supplements restored gut microbiome composition and gut morphology in LPS-exposed mice, as confirmed by microbiome analysis and histological examination.
- 6 March 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (3) , 592
Open AccessEffect of a Combination of Prebiotic Supplements Based on Fucus and Kelp on the Gut Microbiome of Mice with Induced Inflammation
Gut microbiota imbalances can lead to the development of various inflammatory diseases in the body. The development of drugs aimed at maintaining intestinal health is a key area of biotechnology. Algae-based prebiotics are one such drug. The aim of this study was to conduct a comparative analysis of the fecal microbiota of Mus musculus with and without a prebiotic supplement. We studied the effects of enzymatically processed Laminaria digitata and Fucus vesiculosus seaweeds on the gut microbiome of mice with induced inflammation using DNBSEQ-G50 sequencing. The results showed that these prebiotic supplements can reduce the impact of inflammation on the intestine. An increase in the relative abundance of Anaerostipes rhamnosivorans, Dysosmobacter welbionis, Akkermansia muciniphila, Flavonifractor plautii, and a decrease in Longicatena caecimuris relative to the LPS group were observed. Furthermore, enzymatically processed algae were found to increase the relative abundance of gut bacterial metabolic pathways responsible for glucose breakdown. Thus, both enzymatically processed and unprocessed algae-based prebiotic supplements restored gut microbiome composition and gut morphology in LPS-exposed mice, as confirmed by microbiome analysis and histological examination.
- Open Access
- 23 February 2026
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 251, 10894
The effect of short-term consumption of Bifidobacterium bifidum on the gut microbiome of obese individuals
It is known that gut microbiota dysbiosis can lead to obesity by disrupting energy consumption and metabolism. Probiotic supplements are a potential therapeutic option for improving intestinal homeostasis. The aim of this study was to investigate the effect of a probiotic supplement containing Bifidobacterium bifidum on the intestinal microbiome of people with obesity using high-throughput sequencing on the DNBSEQ-G50 platform. The study demonstrated a positive effect of the supplement on bacterial species such as Bacteroides uniformis , Alistipes putredinis , Alistipes shahii , Dysosmobacter welbionis , and Gemmiger formicilis . Therefore, we suggest the potential use of this bacterial species in the treatment of gut microbiota dysbiosis of obese individuals.
- 23 February 2026
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 251, 10894
Open AccessThe effect of short-term consumption of Bifidobacterium bifidum on the gut microbiome of obese individuals
It is known that gut microbiota dysbiosis can lead to obesity by disrupting energy consumption and metabolism. Probiotic supplements are a potential therapeutic option for improving intestinal homeostasis. The aim of this study was to investigate the effect of a probiotic supplement containing Bifidobacterium bifidum on the intestinal microbiome of people with obesity using high-throughput sequencing on the DNBSEQ-G50 platform. The study demonstrated a positive effect of the supplement on bacterial species such as Bacteroides uniformis , Alistipes putredinis , Alistipes shahii , Dysosmobacter welbionis , and Gemmiger formicilis . Therefore, we suggest the potential use of this bacterial species in the treatment of gut microbiota dysbiosis of obese individuals.
- Open Access
- 7 January 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 152-163
Identification and probiotic properties of lactobacilli from the intestines of broiler chickens
The objects of study in this work were the following strains: Pediococcus acidilactici, Lactobacillus johnsonii and Ligilactobacillus salivarius , isolated from the feces of 14-day-old broiler chickens. A sample of broiler chicken feces was placed in a sterile MRS nutrient medium (HiMedia, India) and incubated at 37 ˚C for 24 hours. After that, the analyzed samples were subcultured deeply onto the MRS-agar nutrient medium (SPC Biokompas-S, Russia) using the limiting dilution method to isolate individual colonies of microorganisms. Petri dishes with the cultures were incubated for 48 hours at 37 ˚C. The grown colonies of microorganisms were identified by cultural and morphological characteristics for further sequencing. The resistance of these cultures to bile acids was studied, their antagonistic activity, tolerance to extremely low and high pH values were assessed, and their resistance to different groups of antibiotics was analyzed. L. salivarius was the most resistant to bile compared to L. johnsonii and P. acidilactici . P. acidilactici did not exhibit antagonistic action against the normal microbiota of the gastrointestinal tract, unlike the other analyzed strains, but had a significant effect on opportunistic bacteria. Extremely low and high pH values did not provoke complete death of P. acidilactici , while L. salivarius and L. johnsonii did not retain activity at extremely low pH values. The experiment also revealed that L. johnsonii was the most antibiotic-sensitive strain.
- 7 January 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 152-163
Open AccessIdentification and probiotic properties of lactobacilli from the intestines of broiler chickens
The objects of study in this work were the following strains: Pediococcus acidilactici, Lactobacillus johnsonii and Ligilactobacillus salivarius , isolated from the feces of 14-day-old broiler chickens. A sample of broiler chicken feces was placed in a sterile MRS nutrient medium (HiMedia, India) and incubated at 37 ˚C for 24 hours. After that, the analyzed samples were subcultured deeply onto the MRS-agar nutrient medium (SPC Biokompas-S, Russia) using the limiting dilution method to isolate individual colonies of microorganisms. Petri dishes with the cultures were incubated for 48 hours at 37 ˚C. The grown colonies of microorganisms were identified by cultural and morphological characteristics for further sequencing. The resistance of these cultures to bile acids was studied, their antagonistic activity, tolerance to extremely low and high pH values were assessed, and their resistance to different groups of antibiotics was analyzed. L. salivarius was the most resistant to bile compared to L. johnsonii and P. acidilactici . P. acidilactici did not exhibit antagonistic action against the normal microbiota of the gastrointestinal tract, unlike the other analyzed strains, but had a significant effect on opportunistic bacteria. Extremely low and high pH values did not provoke complete death of P. acidilactici , while L. salivarius and L. johnsonii did not retain activity at extremely low pH values. The experiment also revealed that L. johnsonii was the most antibiotic-sensitive strain.
- Open Access
- 30 December 2025
- Published by FSBEI HE Voronezh State University of Engineering Technologies in Proceedings of the Voronezh State University of Engineering Technologies
- Vol. 87 (4) , 139-148
A study of the effect of free and encapsulated cells of the probiotic strain Weizmannia coagulans on the properties of a probiotic fermented milk product and an assessment of their survival under simulated gastrointestinal conditions
The creation of probiotic fermented milk products, additionally enriched with probiotics, capable of maintaining their viability during storage of the finished product and under the harsh conditions of the gastrointestinal tract (GIT) is a pressing issue. In this study, capsules of alginate, pectin, and κ-carrageenan, additionally coated with chitosan, were produced using an emulsion method, encapsulating cells of the probiotic strain Weizmannia coagulanS. Samples of the probiotic fermented milk product containing free and encapsulated W. coagulans cells were prepared, and the physicochemical, microbiological, and sensory characteristics of the finished product were analyzed. When testing the viability of the capsules in the finished product under simulated GIT conditions, it was found that encapsulated cells demonstrated a high survival rate compared to free cellS. For capsules made of an alginate-pectin mixture (A-P), it was 9.92 Log10 CFU/ml, for capsules made of an alginate-pectin-carrageenan mixture (A-P-C), 10.33 Log10 CFU/ml, the viability of free cells dropped to 2.17 Log10 CFU/ml. Encapsulated and free probiotic cells during storage of a fermented milk product had a significant impact on various characteristics of the finished product. A tendency towards an increase in titratable acidity, a decrease in viscosity, and an increase in syneresis was observed. The viability of free probiotic cells during 21 days of storage decreased by 7.13 Log10 CFU/ml, while the viability of encapsulated cells dropped by only 1.35 Log10 CFU/ml for A-P capsules and by 2.92 Log10 CFU/ml for A-P-C capsuleS. The addition of free and encapsulated cells had little effect on the sensory characteristics of the finished product at the end of its shelf life. The results showed that probiotic encapsulation significantly increased bacterial survival both in the finished product during storage and under simulated gastrointestinal conditions.
- 30 December 2025
- Published by FSBEI HE Voronezh State University of Engineering Technologies in Proceedings of the Voronezh State University of Engineering Technologies
- Vol. 87 (4) , 139-148
Open AccessA study of the effect of free and encapsulated cells of the probiotic strain Weizmannia coagulans on the properties of a probiotic fermented milk product and an assessment of their survival under simulated gastrointestinal conditions
The creation of probiotic fermented milk products, additionally enriched with probiotics, capable of maintaining their viability during storage of the finished product and under the harsh conditions of the gastrointestinal tract (GIT) is a pressing issue. In this study, capsules of alginate, pectin, and κ-carrageenan, additionally coated with chitosan, were produced using an emulsion method, encapsulating cells of the probiotic strain Weizmannia coagulanS. Samples of the probiotic fermented milk product containing free and encapsulated W. coagulans cells were prepared, and the physicochemical, microbiological, and sensory characteristics of the finished product were analyzed. When testing the viability of the capsules in the finished product under simulated GIT conditions, it was found that encapsulated cells demonstrated a high survival rate compared to free cellS. For capsules made of an alginate-pectin mixture (A-P), it was 9.92 Log10 CFU/ml, for capsules made of an alginate-pectin-carrageenan mixture (A-P-C), 10.33 Log10 CFU/ml, the viability of free cells dropped to 2.17 Log10 CFU/ml. Encapsulated and free probiotic cells during storage of a fermented milk product had a significant impact on various characteristics of the finished product. A tendency towards an increase in titratable acidity, a decrease in viscosity, and an increase in syneresis was observed. The viability of free probiotic cells during 21 days of storage decreased by 7.13 Log10 CFU/ml, while the viability of encapsulated cells dropped by only 1.35 Log10 CFU/ml for A-P capsules and by 2.92 Log10 CFU/ml for A-P-C capsuleS. The addition of free and encapsulated cells had little effect on the sensory characteristics of the finished product at the end of its shelf life. The results showed that probiotic encapsulation significantly increased bacterial survival both in the finished product during storage and under simulated gastrointestinal conditions.
- 20 December 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 126
EFFECT OF AKKERMANSIA MUCINIPHILA-BASED PROBIOTIC ON SMALL INTESTINAL MORPHOLOGY AND GENE EXPRESSION AND BEHAVIORAL CHARACTERISTICS OF MICE UNDER INDUCED SYSTEMIC INFLAMMATION
Introduction. The microbiome plays an important role in the normal functioning of the body, an imbalance in its composition leads to various diseases. Currently, many studies are being conducted on the bacterium Akkermansia muciniphila, which is a new generation probiotic that has a beneficial effect on the composition of the microbiome. However, the mechanism of the effect of the bacterium on inflammatory processes occurring in the body and induced by various drugs has not been fully studied. The aim of the study was to determine the effect of A. muciniphila on serum biochemical parameters, as well as behavioral and physiological characteristics of mice during lipopolysaccharide (LPS)-induced systemic inflammation. Material and methods. The following methods were used in the study: physiological test "Open field", biochemical analysis of blood serum using the automatic analyzer "VitaLine 200", histological examination of the small intestine was carried out using hematoxylin and eosin staining, gene expression was assessed by RT-PCR combined with reverse transcription. Statistical processing was performed in the R environment (Version 4.1.1) and Statistica 12, using the Spearman correlation coefficient, the Kruskal–Wallis test and the Bonferroni correction, one-way variance test (ANOVA) using the Tukey post-hoc test. Results. A. muciniphila inhibited the inflammatory process induced by LPS injections and, as a result, led to an increase in research activity. The restoration of the small intestine structure was observed. Also, against the background of the probiotic effect, normalization of the biochemical parameters of the blood serum was revealed. Conclusion. With the combined administration of LPS and A. muciniphila, antioxidant protection (GCLC) and intestinal barrier function (ZO-1) were enhanced, thus, the probiotic demonstrates therapeutic potential in the course of the inflammatory process.
- 20 December 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 126
EFFECT OF AKKERMANSIA MUCINIPHILA-BASED PROBIOTIC ON SMALL INTESTINAL MORPHOLOGY AND GENE EXPRESSION AND BEHAVIORAL CHARACTERISTICS OF MICE UNDER INDUCED SYSTEMIC INFLAMMATION
Introduction. The microbiome plays an important role in the normal functioning of the body, an imbalance in its composition leads to various diseases. Currently, many studies are being conducted on the bacterium Akkermansia muciniphila, which is a new generation probiotic that has a beneficial effect on the composition of the microbiome. However, the mechanism of the effect of the bacterium on inflammatory processes occurring in the body and induced by various drugs has not been fully studied. The aim of the study was to determine the effect of A. muciniphila on serum biochemical parameters, as well as behavioral and physiological characteristics of mice during lipopolysaccharide (LPS)-induced systemic inflammation. Material and methods. The following methods were used in the study: physiological test "Open field", biochemical analysis of blood serum using the automatic analyzer "VitaLine 200", histological examination of the small intestine was carried out using hematoxylin and eosin staining, gene expression was assessed by RT-PCR combined with reverse transcription. Statistical processing was performed in the R environment (Version 4.1.1) and Statistica 12, using the Spearman correlation coefficient, the Kruskal–Wallis test and the Bonferroni correction, one-way variance test (ANOVA) using the Tukey post-hoc test. Results. A. muciniphila inhibited the inflammatory process induced by LPS injections and, as a result, led to an increase in research activity. The restoration of the small intestine structure was observed. Also, against the background of the probiotic effect, normalization of the biochemical parameters of the blood serum was revealed. Conclusion. With the combined administration of LPS and A. muciniphila, antioxidant protection (GCLC) and intestinal barrier function (ZO-1) were enhanced, thus, the probiotic demonstrates therapeutic potential in the course of the inflammatory process.
- Open Access
- 8 December 2025
- Published by MDPI AG in Preprints.org
Genetic Identification of Wood-Destroying Fungi in Weakened Scots Pine (Pinus sylvestris L.) Forests Using DNA Barcoding
Weakened forest stands provide a favorable environment for the development of saprotrophic and necrotrophic fungi. Traditional identification methods for these ecological groups of fungi are not always effective. However, modern DNA barcoding methods based on sequencing DNA regions of the studied fungal specimens and comparing them 31 with the nucleotide sequences of previously classified organisms often allow for precise species identification. Thus, to identify fungi using barcoding in weakened Scots pine (Pinus sylvestris L.) stands in the Central Forest-Steppe of European Russia (Voronezh, Voronezh Region), 55 mycelium and fruiting body samples were collected from conifer litter and Scots pine damaged butt part of the trunk and roots. After morphological and ecological description and systematization of the collection, DNA extraction was performed, the ITS1 and ITS2 regions were sequenced in 21 samples, and 11 species of xylotrophic fungi were identified, of which three species — Hirschioporus fuscoviolaceus (Ehrenb.) Donk, Gymnopilus penetrans (Fr.) Murrill, and Ganoderma applanatum (Pers.) Pat. — infect living wood. The remaining eight representatives of the mycobiota were saprotrophic fungi involved in the mineralization of organic residues. Two phyla, Ascomycota and Basidiomycota, were identified, with the most samples belonging to Basidiomycota and the class Agaricomycetes with seven orders. The predominance of Basidiomycota species indicates stages III-IV mycogenic xylolysis of the weakened stands analyzed. The DNA barcoding method complements the results of morphological and ecological analysis and provides a more complete mycological picture of wood-destroying fungi in weakened pine forests that are difficult to identify.
- 8 December 2025
- Published by MDPI AG in Preprints.org
Open AccessGenetic Identification of Wood-Destroying Fungi in Weakened Scots Pine (Pinus sylvestris L.) Forests Using DNA Barcoding
Weakened forest stands provide a favorable environment for the development of saprotrophic and necrotrophic fungi. Traditional identification methods for these ecological groups of fungi are not always effective. However, modern DNA barcoding methods based on sequencing DNA regions of the studied fungal specimens and comparing them 31 with the nucleotide sequences of previously classified organisms often allow for precise species identification. Thus, to identify fungi using barcoding in weakened Scots pine (Pinus sylvestris L.) stands in the Central Forest-Steppe of European Russia (Voronezh, Voronezh Region), 55 mycelium and fruiting body samples were collected from conifer litter and Scots pine damaged butt part of the trunk and roots. After morphological and ecological description and systematization of the collection, DNA extraction was performed, the ITS1 and ITS2 regions were sequenced in 21 samples, and 11 species of xylotrophic fungi were identified, of which three species — Hirschioporus fuscoviolaceus (Ehrenb.) Donk, Gymnopilus penetrans (Fr.) Murrill, and Ganoderma applanatum (Pers.) Pat. — infect living wood. The remaining eight representatives of the mycobiota were saprotrophic fungi involved in the mineralization of organic residues. Two phyla, Ascomycota and Basidiomycota, were identified, with the most samples belonging to Basidiomycota and the class Agaricomycetes with seven orders. The predominance of Basidiomycota species indicates stages III-IV mycogenic xylolysis of the weakened stands analyzed. The DNA barcoding method complements the results of morphological and ecological analysis and provides a more complete mycological picture of wood-destroying fungi in weakened pine forests that are difficult to identify.